Nectar Lifesciences Limited

NSE:NECLIFE.NS

44.08 (INR) • At close September 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12015 Q42015 Q32014 Q42014 Q3
Omzet 3,592.9974,413.7434,521.7113,979.5713,941.1633,878.9313,441.1943,886.4044,030.1664,762.2664,429.953,645.6333,850.4713,494.8753,773.9524,267.8973,896.2465,647.3316,479.6135,783.5255,753.3217,956.3137,326.0417,238.6335,307.660000
Kosten van de omzet 2,767.8923,465.6643,643.5952,877.8722,791.6752,906.1752,704.0633,086.4622,896.0864,959.3973,250.462,641.0422,844.1513,715.4812,783.7783,295.5893,062.4225,772.585,220.9854,551.2054,430.8277,941.8365,879.9135,862.7894,023.6120000
Brutowinst 825.105948.079878.1161,101.6991,149.488972.756737.131799.9421,134.08-197.1311,179.491,004.5911,006.32-220.606990.174972.308833.824-125.2491,258.6281,232.321,322.49414.4771,446.1281,375.8441,284.0480000
Brutowinstmarge 0.230.2150.1940.2770.2920.2510.2140.2060.281-0.0410.2660.2760.261-0.0630.2620.2280.214-0.0220.1940.2130.230.0020.1970.190.2420000
Onderzoek- en ontwikkelingskosten 0000026.5400030.700024.3500024.4600000000000
Algemene en administratieve kosten 00000000000000000000000000000
Verkoop- en marketingkosten 00000000000000000000000000000
Verkoop-, algemene en administratieve kosten 581.674610.043609.948630.021187.962597.858525.63683.308529.223578.482520.922557.768468.964595.702202.929185.246175.045201.614213.708213.184199.654187.378208.365215.727200.580000
Overige kosten 5.50814.6844.802106.0834.731179.248132.398107.1033.6445.2055.29650.97351.45610.1896.5535.35.179-29.1375.77111.88821.278-587.00915.33614.49613.0970000
Bedrijfskosten 581.674610.043609.948986.175947.41940.677870.5081,021.837862.947-546.087856.379871.558795.43-485.268813.609808.524817.775-514.21850.989891.502866.599-587.009962.338887.522845.4090000
Bedrijfsresultaat 243.431338.036268.168221.607202.078211.327-0.979-114.799271.133348.943323.111133.033210.89264.662176.565163.78416.049388.961407.639340.818455.895601.486483.79488.322438.6390000
Bedrijfsresultaat ratio 0.0680.0770.0590.0560.0510.054-0-0.030.0670.0730.0730.0360.0550.0760.0470.0380.0040.0690.0630.0590.0790.0760.0660.0670.0830000
Totaal overige inkomsten en kosten netto -194.26-226.911-243.603-205.192-171.494-196.691-174.638-209.93-210.023-169.107-170.945-129.121-205.999-621.881-299.79-273.535-273.524-305.249-304.976-314.959-293.419-372.218-344.641-421.039-286.1390000
Inkomen voor belasting 49.171111.12524.56516.41530.58414.636-175.617-324.72961.11179.831152.1663.9124.891-357.219-123.225-109.751-257.47583.712102.66325.859162.476229.268139.14967.283152.50000
Inkomen voor belasting ratio 0.0140.0250.0050.0040.0080.004-0.051-0.0840.0150.0380.0340.0010.001-0.102-0.033-0.026-0.0660.0150.0160.0040.0280.0290.0190.0090.0290000
Belastingkosten 19.48105.2058.8966.26212.38-21.738-82.738-100.01122.11663.23854.852-14.701-13.04952.52-42.514-36.61-88.4369.51820.4891.35525.45854.20730.0888.23719.6680000
Nettowinst 29.6915.92415.66910.15318.20436.373-92.879-224.71838.994116.60397.31418.61317.94-409.749-80.711-73.141-169.03974.19482.17424.504137.018175.061109.06159.046132.8320000
Nettowinstmarge 0.0080.0010.0030.0030.0050.009-0.027-0.0580.010.0240.0220.0050.005-0.117-0.021-0.017-0.0430.0130.0130.0040.0240.0220.0150.0080.0250000
WPA (Winst Per Aandeel) 0.130.030.070.0450.0810.16-0.41-10.170.520.430.080.08-1.83-0.36-0.33-0.750.330.370.110.610.790.490.260.590.320.780.740.75
Verwaterde WPA 0.130.030.070.0450.0810.16-0.41-10.170.520.430.080.08-1.83-0.36-0.33-0.750.330.370.110.610.790.490.260.590.320.730.740.75
EBITDA 398.034485.037421.903374.73360.134359.813146.85933.114421.729313.957471.19325.547405.126-213.372334.132320.012171.738200.258565.688490.436641.208160.431667.902658.27614.6670000
EBITDA ratio 0.1110.110.0930.0940.0910.0930.0430.0090.1050.0660.1060.0890.105-0.0610.0890.0750.0440.0350.0870.0850.1110.020.0910.0910.1160000